[4] Seifert R, Gafita A, Telli T, et al. Standardized PSMA-PET Imaging of Advanced Prostate Cancer. Semin Nucl Med. 2024 Jan;54(1):60-68. [5] Werner RA, Hartrampf PE, Fendler WP, et al. Prostate-specific Membrane Antigen Reporting and Data Syst...
Sartor等[14]和Hofman等[15]经临床试验证实,177Lu-PSMA-617可提高转移性去势抵抗性前列腺癌(metastatic castration-resistant prostate cancer, mCRPC)患者的生存期。随着研究深入,可发射α射线的新型放射性药物如225Ac-PSMA-617 的RLT越来越受到关注。...
Houshmand, S., Lawhn-Heath, C. & Behr, S. PSMA PET imaging in the diagnosis and management of prostate cancer.Abdom Radiol48, 3610–3623 (2023). https:///10.1007/s00261-023-04002-z
参考文献: Fendler, Wolfgang P et al. “PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.” European journal of nuclear medicine and molecular imaging vol. 50,5 (2023): 1466-1486. doi:10.1007/s00259-022-06089-w END 来自:影像核医马平>《...
Posluma最常见的不良反应是腹泻、血压升高和注射部位疼痛。参考来源：‘US FDA approves Blue Earth Diagnostics’ Posluma® (flotufolastat F 18) injection, first radiohybrid PSMA-targeted PET imaging agent for prostate cancer’，新闻发布。Blue Earth Diagnostics；2023年5月30日发布。注：本文旨在介绍医药...
Sartor等[14]和Hofman等[15]经临床试验证实,177Lu-PSMA-617可提高转移性去势抵抗性前列腺癌(metastatic castration-resistant prostate cancer, mCRPC)患者的生存期。随着研究深入,可发射α射线的新型放射性药物如225Ac-PSMA-617 的RLT越来越受到关注。α射线更选择性地向癌细胞提供强效局部辐射,导致更有效的DNA链断裂...
[14]Alipour R, Azad A, Hofman MS. Guiding management of therapy in prostate cancer: time to switch from conventional imaging to PSMA PET?[J]. Ther Adv Med Oncol, 2019, 11: 1-14. [15]Rosar F, Ribbat K, Ries M, et al. Neuron-specific enolase has potential value as a biomarker ...
FDA Approves First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer. News release. FDA. December 1, 2020. Accessed December 23, 2020. https://bit.ly/2VvhoA0 Lantheus Holdings Announces Acceptance and Priority Review of New Drug Application for PyLTM (18F-DCFPyL), a PSMA-Targeted...
参考来源:‘US FDA approves Blue Earth Diagnostics’ Posluma® (flotufolastat F 18) injection, first radiohybrid PSMA-targeted PET imaging agent for prostate cancer’,新闻发布。Blue Earth Diagnostics;2023年5月30日发布。 注:本文旨在介绍医药健康研究,不作任何用药依据,具体用药指引,请咨询主治医师。
1. Rhee H, Thomas P, Shepherd B, el al. Prostate specific membrane antigen positron emission tomography may improve the diagnostic accuracy of multiparametric magnetic resonance imaging in localized prostate cancer. J Urol. 2016; 196:1261-1267. ...